Table 1.
Clinical characteristics and median admission blood tests of patients admitted with COVID-19 to University Hospital, Coventry, between 24 January 2020 and 13 April 2020
| All inpatients, n=321 | ICU admission, n=44 | Non-survivors at discharge, n=104 | |
|---|---|---|---|
| Median age, years (IQR) | 73 (56.0–82.0) | 59 (49.0–68.0) | 80 (72.0–88.0) |
| Age >65, years (%) | 198 (61.7) | 15 (34.1) ap=0.026 |
88 (84.6) bp=0.011 |
| Male, n (%) | 189 (58.9) | 33 (75.0) ap=0.027 |
62 (60.0) |
| BAME, n (%) | 75 (23.3) | 18 (40.9) ap=0.008 |
19 (18.2) |
| Any comorbidity, n (%) | 259 (80.6) | 33 (75.0) | 88 (84.6) |
| Heart disease, n (%) | 86 (26.7) | 4 (9.0) ap=0.009 |
32 (30.7) |
| NLR (IQR) | 6.1 (3.6–10.3) | 6.9 (4.9–10.8) | 7.2 (4.6–13.0) bp=0.028 |
| CRP, mg/L (IQR) | 79 (32.5–162.0) | 149 (64.0–215.0) ap<0.001 |
129 (51.0–222.0) bp<0.001 cp<0.001 |
| Albumin, g/L (IQR) | 38 (34.0–40.0) | 38 (34.7–40.2) | 37 (32.0–39.0) bp=0.002 cp=0.005 |
a = significant value for association with hospital care;
b = significant value for relationship with mortality;
c = significant value for association with mortality, adjusted for age; BAME = black, Asian and minority ethnic; CRP=C-reactive protein; ICU = intensive care unit; IQR = interquartile range; NLR = neutrophil:lymphocyte ratio.